The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

The FDA announced this week it had decided to revoke Red 3's authorization to be added to foods, over concerns about how the food coloring dye has been linked to cancer in laboratory animals.

Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, yellow No. 5 and others.

The FDA has banned red dye No. 3 in food and ingested drugs, the agency announced. But what exactly is red dye No. 3, and why is it being banned? Here's what you need to know.

Red Dye No. 3, also known as erythrosine, is a synthetic food dye that gives foods and drinks a bright red color. It is also sometimes used in oral medicines and dietary supplements. It first was approved for use in food in 1907. It's made from petroleum.

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.

Already banned in cosmetics and topical medicines since 1990, the Food and Drug Administration announced on Wednesday that Red 3 will now be banned in food, drink, and ingestible medications.